METTLER TOLEDO
 

Solutions for the Pharmaceutical and Biotech Industries

METTLER TOLEDO provides innovative solutions supporting the development and manufacturing of Pharmaceutical and Biotech products. Following the principles of Quality by Design (QbD), our technologies provide the capability to quickly and efficiently develop an understanding of the appropriate design space using state of the art Automated Lab Reactors for accurate control of test conditions, and in situ Process Analytical Technologies (PAT) for real-time monitoring and control of Critical Quality Attributes (CQA) in the development and manufacturing of both the active ingredient (API) and the final formulated drug product.
For the Bio/pharmaceutical industries, METTLER TOLEDO offers solutions in these specific application areas:

In the early stages of chemical development, MiniBlock® parallel reactor blocks offer the ability to screen and optimize liquid phase synthesis and solid phase synthesis routes. As the development process continues, reaction characterization and optimization can proceed to larger scale multiple vessel (EasyMaxTMMultiMaxTM) and single vessel (LabMax®RC1eTM) systems. All of our reactor systems are designed and manufactured to ensure safe and accurately controlled operation under a wide range of experimental conditions.

Real Time Analytics available for PAT monitoring include calorimetry (RC1eTMRTCalTM), FTIR (ReactIRTM) and particle characterization (FBRM®PVM®). A common software platform (iC software) is available with most available instruments to simplify the execution and analysis of data rich experiments – freeing vast amounts of the researcher’s time allowing greater creativity and productivity.

The majority of industry specialty labs focused on Process Safety and Crystallization have embraced the reliability of METTLER TOLEDO solutions as standard methods in their development toolboxes.

PAT tools for FTIR reaction monitoring (MonARCTM) and particle characterization (FBRM®) are also available for monitoring in a GMP pilot plant or production environment, allowing knowledge developed at the laboratory scale to be used in a production setting for testing scale-up assumptions and ensuring batch to batch consistency in the manufacturing of API and formulated products.